Medical Sciences


Synergistic Composition for Drug Sensitization and Therapy in Cancer


Medical Sciences

Focus Area:

Cancer Treatment


US8012952, US9364566, US9861653,

Social Benefits:

A glucocorticoid receptor (GR)-based platform technology: carries multiple drugs induces targeted drug sensitization, EMT-reversal and kills drug- resistant cancer cells and cancer stem cells (CSCs); hence, suited to also treat cancer relapse. The technology repurposes a typical cancer drugs against multiple cancers

Developing Agency:

CSIR-Indian Institute of Chemical Technology (IICT), Telangana

Technology Readiness Index:

Technology Development

Website Link :
Source (more info) :

Brief Description

Description :

Tested in orthotopic and humanoid models of various cancers in association with Mayo Clinic, USA

Related Technologies